Theravance Biopharma, Inc.·4

May 22, 6:11 PM ET

Shafer Bradford J 4

4 · Theravance Biopharma, Inc. · Filed May 22, 2020

Insider Transaction Report

Form 4
Period: 2020-05-20
Shafer Bradford J
Sr VP, Gen. Counsel, Secretary
Transactions
  • Tax Payment

    Ordinary Shares

    2020-05-20$26.67/sh4,807$128,203261,527 total
Footnotes (1)
  • [F1]Includes 1,402 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2020.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -